Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $13,326 | 1 | 73.2% |
| Consulting Fee | $3,725 | 1 | 20.5% |
| Food and Beverage | $581.50 | 22 | 3.2% |
| Education | $570.00 | 6 | 3.1% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ACADIA Pharmaceuticals Inc | $13,971 | 8 | $0 (2019) |
| Acorda Therapeutics, Inc | $3,725 | 1 | $0 (2020) |
| Amneal Pharmaceuticals LLC | $217.36 | 14 | $0 (2024) |
| INSIGHTEC,INC | $134.36 | 1 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $73.16 | 1 | $0 (2023) |
| Allergan Inc. | $70.56 | 4 | $0 (2017) |
| Mitsubishi Tanabe Pharma America, Inc. | $11.39 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $171.50 | 12 | Amneal Pharmaceuticals LLC ($171.50) |
| 2023 | $119.02 | 3 | Neurocrine Biosciences, Inc. ($73.16) |
| 2022 | $134.36 | 1 | INSIGHTEC,INC ($134.36) |
| 2020 | $3,725 | 1 | Acorda Therapeutics, Inc ($3,725) |
| 2019 | $540.00 | 5 | ACADIA Pharmaceuticals Inc ($540.00) |
| 2018 | $41.39 | 2 | ACADIA Pharmaceuticals Inc ($30.00) |
| 2017 | $13,471 | 6 | ACADIA Pharmaceuticals Inc ($13,401) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Amneal Pharmaceuticals LLC | ONGENTYS (Drug) | Food and Beverage | In-kind items and services | $9.29 | General |
| Category: NEUROLOGY | ||||||
| 10/21/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: NEUROLOGY | ||||||
| 08/20/2024 | Amneal Pharmaceuticals LLC | ONGENTYS 50MG CAPSULES 30 (Drug) | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: NEUROLOGY | ||||||
| 08/05/2024 | Amneal Pharmaceuticals LLC | ONGENTYS 50MG CAPSULES 30 (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: NEUROLOGY | ||||||
| 05/23/2024 | Amneal Pharmaceuticals LLC | ONGENTYS (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: NEUROLOGY | ||||||
| 05/21/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: NEUROLOGY | ||||||
| 04/09/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: NEUROLOGY | ||||||
| 03/19/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: NEUROLOGY | ||||||
| 02/26/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: NEUROLOGY | ||||||
| 02/07/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: NEUROLOGY | ||||||
| 01/23/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: NEUROLOGY | ||||||
| 01/03/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: NEUROLOGY | ||||||
| 12/04/2023 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $29.46 | General |
| Category: NEUROLOGY | ||||||
| 08/21/2023 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: NEUROLOGY | ||||||
| 05/15/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $73.16 | General |
| Category: Neuropsychiatry | ||||||
| 03/23/2022 | INSIGHTEC,INC | Exablate (Device) | Food and Beverage | Cash or cash equivalent | $134.36 | General |
| Category: Neurology | ||||||
| 06/11/2020 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Consulting Fee | Cash or cash equivalent | $3,725.00 | General |
| Category: PARKINSONS DISEASE | ||||||
| 07/15/2019 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Education | In-kind items and services | $250.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 07/15/2019 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Education | In-kind items and services | $250.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 07/09/2019 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Education | In-kind items and services | $30.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 02/01/2019 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Education | In-kind items and services | $5.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 02/01/2019 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Education | In-kind items and services | $5.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/30/2018 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Education | In-kind items and services | $30.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/02/2018 | Mitsubishi Tanabe Pharma America, Inc. | Radicava (Drug) | Food and Beverage | Cash or cash equivalent | $11.39 | General |
| Category: Amyotrophic Lateral Sclerosis | ||||||
| 08/04/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: NEUROSCIENCE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ACP-103-015 | ACADIA Pharmaceuticals Inc | $13,326 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 447 | 733 | $245,503 | $59,044 |
| 2022 | 4 | 481 | 762 | $242,814 | $58,232 |
| 2021 | 4 | 567 | 954 | $252,459 | $73,809 |
| 2020 | 7 | 740 | 994 | $234,896 | $62,055 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 317 | 583 | $175,483 | $41,207 | 23.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 66 | 66 | $34,320 | $9,071 | 26.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 64 | 84 | $35,700 | $8,767 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 341 | 606 | $179,502 | $42,297 | 23.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 78 | 94 | $38,990 | $10,187 | 26.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 38 | 38 | $19,376 | $4,658 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 24 | 24 | $4,946 | $1,089 | 22.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 409 | 789 | $202,773 | $58,538 | 28.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 68 | 68 | $26,452 | $7,149 | 27.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 41 | 48 | $16,560 | $5,645 | 34.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 49 | 49 | $6,674 | $2,477 | 37.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 408 | 633 | $162,681 | $36,701 | 22.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 164 | 189 | $18,458 | $11,364 | 61.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 83 | 83 | $32,287 | $8,439 | 26.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 25 | 28 | $9,660 | $2,517 | 26.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 31 | 31 | $4,754 | $1,228 | 25.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 12 | 12 | $5,868 | $1,171 | 20.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 17 | 18 | $1,188 | $635.02 | 53.5% |
About Dr. Joseph Friedman, MD
Dr. Joseph Friedman, MD is a Neurology healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1477549632.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Friedman, MD has received a total of $18,203 in payments from pharmaceutical and medical device companies, with $171.50 received in 2024. These payments were reported across 30 transactions from 7 companies. The most common payment nature is "" ($13,326).
As a Medicare-enrolled provider, Friedman has provided services to 2,235 Medicare beneficiaries, totaling 3,443 services with total Medicare billing of $253,140. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Providence, RI
- Active Since 09/23/2005
- Last Updated 07/25/2024
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1477549632
Products in Payments
- NUPLAZID (Drug) $13,971
- INBRIJA (Drug) $3,725
- RYTARY (Drug) $152.85
- Exablate (Device) $134.36
- INGREZZA (Drug) $73.16
- VRAYLAR (Drug) $70.56
- ONGENTYS 50MG CAPSULES 30 (Drug) $25.82
- ONGENTYS (Drug) $23.84
- CREXONT (Drug) $14.85
- Radicava (Drug) $11.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Providence
Syed Rizvi, Md, MD
Neurology — Payments: $482,996
Stephen Salloway, Md, MD
Neurology — Payments: $323,920
J Easton, Md, MD
Neurology — Payments: $274,886
Jeffrey Wishik, Md, MD
Neurology — Payments: $46,542
Dr. Karen Furie, Md, MD
Neurology — Payments: $31,250
Dr. Chuang-Kuo Wu, M.d., Phd, M.D., PHD
Neurology — Payments: $27,531